285 related articles for article (PubMed ID: 17022964)
1. Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction.
Koch M; Spillmann F; Dendorfer A; Westermann D; Altmann C; Sahabi M; Linthout SV; Bader M; Walther T; Schultheiss HP; Tschöpe C
Eur J Pharmacol; 2006 Nov; 550(1-3):143-8. PubMed ID: 17022964
[TBL] [Abstract][Full Text] [Related]
2. Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene.
Tschöpe C; Walther T; Königer J; Spillmann F; Westermann D; Escher F; Pauschinger M; Pesquero JB; Bader M; Schultheiss HP; Noutsias M
FASEB J; 2004 May; 18(7):828-35. PubMed ID: 15117887
[TBL] [Abstract][Full Text] [Related]
3. [A comparative study of cardiac function in transgenic hypertensive rats, in spontaneously hypertensive rats and in normotensive rats].
Bohlender J; Hildenbrand U; Schlegel WP; Hempel P; Nissen E; Krause EG; Bartel S
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):993-6. PubMed ID: 10989744
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone attenuates cardiac remodeling and improves hemodynamics early after acute myocardial infarction in rats.
Pantos C; Mourouzis I; Markakis K; Dimopoulos A; Xinaris C; Kokkinos AD; Panagiotou M; Cokkinos DV
Eur J Cardiothorac Surg; 2007 Aug; 32(2):333-9. PubMed ID: 17560116
[TBL] [Abstract][Full Text] [Related]
5. [Effects of perindopril on left ventricular remodeling and myocardial osteopontin expression in rats with myocardial infarction].
Zhang YL; Zhou SX; Wang MH; Wang JF
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1584-8. PubMed ID: 17121705
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model.
Koch M; Bonaventura K; Spillmann F; Dendorfer A; Schultheiss HP; Tschöpe C
Biol Chem; 2008 Jun; 389(6):719-23. PubMed ID: 18627293
[TBL] [Abstract][Full Text] [Related]
7. [Induction of left ventricular remodeling and dysfunction in the recipient heart following donor heart myocardial infarction: new insights into the pathological role of tumor necrosis factor-alpha from a novel heterotopic transplant-coronary ligation model].
Nakamura H; Takata S; Umemoto S; Matsuzaki M
J Cardiol; 2003 Jan; 41(1):41-2. PubMed ID: 12564114
[TBL] [Abstract][Full Text] [Related]
8. Increased kallikrein expression protects against cardiac ischemia.
Pinto YM; Bader M; Pesquero JB; Tschöpe C; Scholtens E; van Gilst WH; Buikema H
FASEB J; 2000 Oct; 14(13):1861-3. PubMed ID: 11023968
[TBL] [Abstract][Full Text] [Related]
9. Local myocardial overexpression of growth hormone attenuates postinfarction remodeling and preserves cardiac function.
Jayasankar V; Bish LT; Pirolli TJ; Berry MF; Burdick J; Woo YJ
Ann Thorac Surg; 2004 Jun; 77(6):2122-9; discussion 2129. PubMed ID: 15172279
[TBL] [Abstract][Full Text] [Related]
10. Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in rats.
Pantos C; Mourouzis I; Markakis K; Tsagoulis N; Panagiotou M; Cokkinos DV
Basic Res Cardiol; 2008 Jul; 103(4):308-18. PubMed ID: 18274800
[TBL] [Abstract][Full Text] [Related]
11. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
[TBL] [Abstract][Full Text] [Related]
12. Protective actions of human tissue kallikrein gene in transgenic rat hearts.
Silva JA; Silva MR; Nascimento JW; Bader M; Pesquero JB
Int Immunopharmacol; 2008 Feb; 8(2):267-70. PubMed ID: 18182238
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of doxycycline, losartan, and their combination in the prevention of post-infarction remodeling in rats].
Yang YJ; Zhang P; Ruan YM; Chen X; Zhou YW; Tian Y; Gao RL; Chen ZJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):479-85. PubMed ID: 16178444
[TBL] [Abstract][Full Text] [Related]
14. Adaptive or maladaptive response to adenoviral adrenomedullin gene transfer is context-dependent in the heart.
Leskinen H; Rauma-Pinola T; Szokodi I; Kerkelä R; Pikkarainen S; Uusimaa P; Hautala T; Vuolteenaho O; Ruskoaho H
J Gene Med; 2008 Aug; 10(8):867-77. PubMed ID: 18615773
[TBL] [Abstract][Full Text] [Related]
15. [Effects of Trimetazidine upon ventricular remodeling and GLUT4 in diabetic rats after myocardial infarction].
Zhang RY; Yu P; Wang F; Shen JX; Wang YM
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1240-5. PubMed ID: 19595176
[TBL] [Abstract][Full Text] [Related]
16. Swimming exercise training prior to acute myocardial infarction attenuates left ventricular remodeling and improves left ventricular function in rats.
Dayan A; Feinberg MS; Holbova R; Deshet N; Scheinowitz M
Ann Clin Lab Sci; 2005; 35(1):73-8. PubMed ID: 15830712
[TBL] [Abstract][Full Text] [Related]
17. Effect of peroxisome proliferator-activated receptor gamma ligand. Rosiglitazone on left ventricular remodeling in rats with myocardial infarction.
Geng DF; Wu W; Jin DM; Wang JF; Wu YM
Int J Cardiol; 2006 Oct; 113(1):86-91. PubMed ID: 16891009
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression with an interleukin-2 fusion protein leads to improved LV function in experimental ischemic cardiomyopathy.
Koch M; Savvatis K; Scheeler M; Dhayat S; Bonaventura K; Pohl T; Riad A; Bulfone-Paus S; Schultheiss HP; Tschöpe C
Int Immunopharmacol; 2010 Feb; 10(2):207-12. PubMed ID: 19897056
[TBL] [Abstract][Full Text] [Related]
19. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
20. Effects of G-CSF on cardiac remodeling and arterial hyperplasia in rats.
Li Y; Fukuda N; Yokoyama S; Kusumi Y; Hagikura K; Kawano T; Takayama T; Matsumoto T; Satomi A; Honye J; Mugishima H; Mitsumata M; Saito S
Eur J Pharmacol; 2006 Nov; 549(1-3):98-106. PubMed ID: 16979158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
